Performance of TechLab C. DIFF QUIK CHEK™ and TechLab C. DIFFICILE TOX A/B II™ for the detection of clostridium difficile in stool samples

被引:25
作者
Reyes, Romina C. [1 ]
John, Michael A. [1 ]
Ayotte, Diane L. [1 ]
Covacich, Alexia [1 ]
Milburn, Susan [1 ]
Hussain, Zafar [1 ]
机构
[1] Victoria Hosp, London Hlth Sci Ctr, Dept Med Microbiol, London, ON N6C 6B5, Canada
关键词
clostridium difficile; membrane immunoassay; diarrhea;
D O I
10.1016/j.diagmicrobio.2007.04.018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Two membrane-bound enzyme immunoassays by TechLab, Blacksburg, VA, were evaluated and compared with the Triage (R) Micro C difficile Panel (Biosite Diagnostics, San Diego, CA), with culture, and with cytotoxic assay. The TechLab panels were C. DIFF QUIK CHEK (TM) (QC-GDH) and C. DIFFICILE TOX A/B II (TM) (QC-toxinA/B), which detect glutamate dehydrogenase (GDH) and Clostridium difficile toxins A and B, respectively. The Triage Panel detects GDH (TR-GDH) and toxin A (TR-toxinA). Stool samples were inoculated onto CCFA plates (Q-Labs, Quebec, Canada) after alcohol shock, and suspected colonies were identified by the MicroScreen C. difficile latex slide agglutination test (Microgen Bioproducts, Surrey, UK). TR-GDH, TR-toxinA, QC-GDH, and QC-toxinA/B tests were performed according to the manufacturers' instructions on all the samples. Samples positive for GDH or culture but negative for TR-toxinA and QC-toxinA/B were further tested by cytotoxin assay (CTA). CTA was also performed on samples that caused blackening of the Triage (R) Micro C. difficile Panel. A total of 313 of 401 stool samples were negative for GDH and toxins (78%). Eighty-eight samples were positive either for GDH or culture or both. Thirteen of these could not be evaluated for C. difficile-associated diarrhea (CDAD) because CTA test was not performed. Toxin/s was detected at least by one method in 46 (11.8%) of 388 samples that were positive for culture or GDH and were considered diagnostic of CDAD. The QC-GDH was more sensitive than culture and TR-GDH for the detection of C difficile. However, in 18 GDH-positive samples positive for either of the Triage or TechLab immunoassays, the culture remained negative. Ten (2%) results of the Triage immunoassays could not be evaluated because of discoloration of the panels. QC-GDH (93.5%) was more sensitive for detecting the presence of toxin-producing C. difficile than TR-GDH (79.5%). TR-toxinA was more specific for detecting the presence of toxin-producing C. difficile than QC-toxinA/B (100% and 96.9%, respectively). The GDH tests had a faster turnaround time than the traditional culture methods. QC-GDH was most sensitive for the detection C. difficile-positive stools and was easy to use. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 19 条
[1]   Usefulness of simultaneous detection of toxin A and glutamate dehydrogenase for the diagnosis of Clostridium difficile-associated diseases [J].
Barbut, F ;
Lalande, V ;
Daprey, G ;
Cohen, P ;
Marle, N ;
Burghoffer, B ;
Petit, JC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (06) :481-484
[2]   A European survey of diagnostic methods and testing protocols for Clostridium difficile [J].
Barbut, F ;
Delmée, M ;
Brazier, JS ;
Petit, JC ;
Poxton, IR ;
Rupnik, M ;
Lalande, V ;
Schneider, C ;
Mastrantonio, P ;
Alonso, R ;
Kuipjer, E ;
Tvede, M .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (10) :989-996
[3]   Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin [J].
Borek, AP ;
Aird, DZ ;
Carroll, KC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (06) :2994-2995
[4]   The diagnosis of Clostridium difficile-associated disease [J].
Brazier, JS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 :29-40
[5]   LABORATORY DIAGNOSIS OF CLOSTRIDIUM-DIFFICILE-ASSOCIATED GASTROINTESTINAL-DISEASE - COMPARISON OF A MONOCLONAL-ANTIBODY ENZYME-IMMUNOASSAY FOR TOXIN-A AND TOXIN-B WITH A MONOCLONAL-ANTIBODY ENZYME-IMMUNOASSAY FOR TOXIN-A ONLY AND 2 CYTOTOXICITY ASSAYS [J].
DOERN, GV ;
COUGHLIN, RT ;
WU, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (08) :2042-2046
[6]  
FEKETY R, 1997, J CLIN MICROBIOL, V92, P730
[7]  
GEORGE WL, 1979, J CLIN MICROBIOL, V9, P214
[8]  
GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459
[9]   International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants [J].
Johnson, S ;
Sambol, SP ;
Brazier, JS ;
Delmée, M ;
Avesani, V ;
Merrigan, MM ;
Gerding, DN .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (04) :1543-1547
[10]   Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile [J].
Kyne, L ;
Hamel, MB ;
Polavaram, R ;
Kelly, CNP .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (03) :346-353